加拿大是否应该为昂贵的药物在加拿大采用管理访问协议?
Melanie McPhail1, Tania Bubela1
1Faculty of Health Sciences, Simon Fraser University, Burnaby V5A 1S6, Canada.
Journal of law and the biosciences
|June 19, 2023
概括
管理访问协议 (MAA) 为药物退款的不确定性提供了解决方案. 加拿大的法律和政策障碍表明,省级或准联邦的方法比泛加拿大的MAA采用框架更可行.
科学领域:
- 卫生经济学 卫生经济学
- 制药政策 制药政策
- 法律分析 法律分析
背景情况:
- 药物越来越多地在有限的证据基础上获得批准,这给付款人带来了报销挑战.
- 付款人面临两难境地:偿还可能不具有成本效益的药物或延迟获得有益药物的机会.
- 管理访问协议 (MAA) 提供了一个新的框架来解决这些退款不确定性.
研究的目的:
- 提供对在加拿大采用MAA的法律限制,考虑和影响的全面概述.
- 分析泛加拿大MAA治理框架的可行性与替代方法相比.
- 为制定有关在加拿大实施MAA的政策提出建议.
主要方法:
- 审查加拿大目前的药品报销流程.
- 对MAA术语,定义和国际经验的分析.
- 对MAA的障碍,设计,实施和政策影响的法律分析.
主要成果:
- 严重的法律和政策障碍阻碍了全加拿大MAA治理框架的采用.
- 现有的基础设施可以支持准联邦或省级的MAA方法.
- 国际经验为MAA实施提供了洞察力.
结论:
- 目前,由于法律和政策障碍,一个泛加拿大MAA治理框架是不可行的.
- 省级或准联邦的MAA框架更实用,利用现有基础设施.
- 政策制定应该考虑这些局限性以及在加拿大实施MAA的可行替代方案.
相关概念视频
Drug Control Governance: Regulatory Bodies and Their Impact
195
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
195
Prescription, Nonprescription and Orphan Drugs
789
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
789
Drug Nomenclature
1.8K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
1.8K
Drug Dosage Regimen: Overview
3.6K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.6K
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Drug Distribution: Tissue Binding
2.7K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
2.7K


